Adagene to Present at Leerink’s Global Healthcare Conference 2025
Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based ...
Le Lézard14h
Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference
SLN ("Silence" or the "Company"), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced that management will present a company overview at the ...
VYNE Therapeutics Reports 2024 Fourth Quarter and Year-End Financial Results and Provides Business Update
Phase 2b vitiligo top-line results expected in mid-2025VYN202 Phase 1b psoriasis trial initiated with results anticipated ...
Mind Medicine (MindMed) Inc. (MNMD) Q4 2024 Earnings Call Transcript
Mind Medicine (MindMed) Inc. ( NASDAQ: MNMD) Q4 2024 Earnings Conference Call March 6, 2025 8:00 AM ET Stephanie Fagan - Chief Corporate Affairs Officer Rob Barrow - CEO Dan Karlin - CMO ...
Cantargia to Participate at H.C. Wainwright's Annual Autoimmune & Inflammatory Virtual Conference
Cantargia AB (publ) ("Cantargia") (Nasdaq Stockholm: CANTA) today announced that Damian Marron, Interim CEO, will participate at the H.C.
The Manila Times21h
Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates
CAMBRIDGE, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company ...
Le Lézard20h
Marvell Technology, Inc. Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Marvell Technology, Inc. , a leader in data infrastructure semiconductor solutions, today reported financial results for the fourth fiscal quarter and fiscal year ended February 1, 2025. Net revenue ...